Literature DB >> 22556411

Proteomic analysis of wild-type and mutant huntingtin-associated proteins in mouse brains identifies unique interactions and involvement in protein synthesis.

Brady P Culver1, Jeffrey N Savas, Sung K Park, Jeong H Choi, Shuqiu Zheng, Scott O Zeitlin, John R Yates, Naoko Tanese.   

Abstract

Huntington disease is a neurodegenerative disorder caused by a CAG repeat amplification in the gene huntingtin (HTT) that is reflected by a polyglutamine expansion in the Htt protein. Nearly 20 years of research have uncovered roles for Htt in a wide range of cellular processes, and many of these discoveries stemmed from the identification of Htt-interacting proteins. However, no study has employed an impartial and comprehensive strategy to identify proteins that differentially associate with full-length wild-type and mutant Htt in brain tissue, the most relevant sample source to the disease condition. We analyzed Htt affinity-purified complexes from wild-type and HTT mutant juvenile mouse brain from two different biochemical fractions by tandem mass spectrometry. We compared variations in protein spectral counts relative to Htt to identify those proteins that are the most significantly contrasted between wild-type and mutant Htt purifications. Previously unreported Htt interactions with Myo5a, Prkra (PACT), Gnb2l1 (RACK1), Rps6, and Syt2 were confirmed by Western blot analysis. Gene Ontology analysis of these and other Htt-associated proteins revealed a statistically significant enrichment for proteins involved in translation among other categories. Furthermore, Htt co-sedimentation with polysomes in cytoplasmic mouse brain extracts is dependent upon the presence of intact ribosomes. Finally, wild-type or mutant Htt overexpression inhibits cap-dependent translation of a reporter mRNA in an in vitro system. Cumulatively, these data support a new role for Htt in translation and provide impetus for further study into the link between protein synthesis and Huntington disease pathogenesis.

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 22556411      PMCID: PMC3381125          DOI: 10.1074/jbc.M112.359307

Source DB:  PubMed          Journal:  J Biol Chem        ISSN: 0021-9258            Impact factor:   5.157


  70 in total

1.  Shotgun identification of protein modifications from protein complexes and lens tissue.

Authors:  Michael J MacCoss; W Hayes McDonald; Anita Saraf; Rovshan Sadygov; Judy M Clark; Joseph J Tasto; Kathleen L Gould; Dirk Wolters; Michael Washburn; Avery Weiss; John I Clark; John R Yates
Journal:  Proc Natl Acad Sci U S A       Date:  2002-06-11       Impact factor: 11.205

2.  Automatic quality assessment of peptide tandem mass spectra.

Authors:  Marshall Bern; David Goldberg; W Hayes McDonald; John R Yates
Journal:  Bioinformatics       Date:  2004-08-04       Impact factor: 6.937

3.  Extensive early motor and non-motor behavioral deficits are followed by striatal neuronal loss in knock-in Huntington's disease mice.

Authors:  M A Hickey; A Kosmalska; J Enayati; R Cohen; S Zeitlin; M S Levine; M-F Chesselet
Journal:  Neuroscience       Date:  2008-08-27       Impact factor: 3.590

4.  BDNF-mediated neurotransmission relies upon a myosin VI motor complex.

Authors:  Hiroko Yano; Ipe Ninan; Hong Zhang; Teresa A Milner; Ottavio Arancio; Moses V Chao
Journal:  Nat Neurosci       Date:  2006-07-02       Impact factor: 24.884

5.  PANTHER pathway: an ontology-based pathway database coupled with data analysis tools.

Authors:  Huaiyu Mi; Paul Thomas
Journal:  Methods Mol Biol       Date:  2009

6.  Chronic mitochondrial energy impairment produces selective striatal degeneration and abnormal choreiform movements in primates.

Authors:  E Brouillet; P Hantraye; R J Ferrante; R Dolan; A Leroy-Willig; N W Kowall; M F Beal
Journal:  Proc Natl Acad Sci U S A       Date:  1995-07-18       Impact factor: 11.205

7.  Huntingtin is a cytoplasmic protein associated with vesicles in human and rat brain neurons.

Authors:  M DiFiglia; E Sapp; K Chase; C Schwarz; A Meloni; C Young; E Martin; J P Vonsattel; R Carraway; S A Reeves
Journal:  Neuron       Date:  1995-05       Impact factor: 17.173

8.  Functional gene expression profiling in yeast implicates translational dysfunction in mutant huntingtin toxicity.

Authors:  Eran Tauber; Leonor Miller-Fleming; Robert P Mason; Wanda Kwan; Jannine Clapp; Nicola J Butler; Tiago F Outeiro; Paul J Muchowski; Flaviano Giorgini
Journal:  J Biol Chem       Date:  2010-11-02       Impact factor: 5.157

Review 9.  Neurodegenerative processes in Huntington's disease.

Authors:  D Bano; F Zanetti; Y Mende; P Nicotera
Journal:  Cell Death Dis       Date:  2011-11-10       Impact factor: 8.469

10.  RNA-binding proteins TIA-1 and TIAR link the phosphorylation of eIF-2 alpha to the assembly of mammalian stress granules.

Authors:  N L Kedersha; M Gupta; W Li; I Miller; P Anderson
Journal:  J Cell Biol       Date:  1999-12-27       Impact factor: 10.539

View more
  57 in total

1.  Global Proteome and Ubiquitinome Changes in the Soluble and Insoluble Fractions of Q175 Huntington Mice Brains.

Authors:  Karen A Sap; Arzu Tugce Guler; Karel Bezstarosti; Aleksandra E Bury; Katrin Juenemann; Jeroen A A Demmers; Eric A Reits
Journal:  Mol Cell Proteomics       Date:  2019-05-28       Impact factor: 5.911

2.  Proteomic analysis of host brain components that bind to infectious particles in Creutzfeldt-Jakob disease.

Authors:  Terry Kipkorir; Christopher M Colangelo; Laura Manuelidis
Journal:  Proteomics       Date:  2015-06-09       Impact factor: 3.984

3.  A large scale Huntingtin protein interaction network implicates Rho GTPase signaling pathways in Huntington disease.

Authors:  Cendrine Tourette; Biao Li; Russell Bell; Shannon O'Hare; Linda S Kaltenbach; Sean D Mooney; Robert E Hughes
Journal:  J Biol Chem       Date:  2014-01-09       Impact factor: 5.157

Review 4.  Recent advances in quantitative neuroproteomics.

Authors:  George E Craft; Anshu Chen; Angus C Nairn
Journal:  Methods       Date:  2013-04-25       Impact factor: 3.608

Review 5.  The many faces of autophagy dysfunction in Huntington's disease: from mechanism to therapy.

Authors:  Constanza J Cortes; Albert R La Spada
Journal:  Drug Discov Today       Date:  2014-03-13       Impact factor: 7.851

6.  Quantitative Proteomic Analysis Reveals Similarities between Huntington's Disease (HD) and Huntington's Disease-Like 2 (HDL2) Human Brains.

Authors:  Tamara Ratovitski; Raghothama Chaerkady; Kai Kammers; Jacqueline C Stewart; Anialak Zavala; Olga Pletnikova; Juan C Troncoso; Dobrila D Rudnicki; Russell L Margolis; Robert N Cole; Christopher A Ross
Journal:  J Proteome Res       Date:  2016-08-03       Impact factor: 4.466

Review 7.  Molecular insights into cortico-striatal miscommunications in Huntington's disease.

Authors:  Matthew B Veldman; X William Yang
Journal:  Curr Opin Neurobiol       Date:  2017-11-07       Impact factor: 6.627

Review 8.  New insight into neurodegeneration: the role of proteomics.

Authors:  Ramavati Pal; Guido Alves; Jan Petter Larsen; Simon Geir Møller
Journal:  Mol Neurobiol       Date:  2013-12-10       Impact factor: 5.590

9.  D-polyglutamine amyloid recruits L-polyglutamine monomers and kills cells.

Authors:  Karunakar Kar; Irene Arduini; Kenneth W Drombosky; Patrick C A van der Wel; Ronald Wetzel
Journal:  J Mol Biol       Date:  2013-11-28       Impact factor: 5.469

10.  Experimental models for identifying modifiers of polyglutamine-induced aggregation and neurodegeneration.

Authors:  Barbara Calamini; Donald C Lo; Linda S Kaltenbach
Journal:  Neurotherapeutics       Date:  2013-07       Impact factor: 7.620

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.